Trademark: 79360076
Word
TME PHARMA
Status Date
Tuesday, June 25, 2024
Registration Number
7423863
Registration Date
Tuesday, June 25, 2024
Filing Date
Thursday, November 3, 2022
Published for Opposition
Tuesday, April 9, 2024
5 Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;
1 Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;
44 Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;
42 Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory services
The mark consists of the stylized blue wording 'TME pharma' stacked to the left of a design comprised of a light blue circle containing transparent lines partially surrounded by a light green and blue curved line.
The color(s) blue, green and light blue is/are claimed as a feature of the mark.
TME PHARMA
Aug 18, 2023
Assigned To Examiner
Jan 12, 2023
Sn Assigned For Sect 66a Appl From Ib
Jan 13, 2023
New Application Office Supplied Data Entered
Jan 17, 2023
Application Filing Receipt Mailed
Aug 22, 2023
Non-Final Action Written
Aug 23, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 13, 2023
Refusal Processed By Mpu
Sep 14, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 11, 2023
Refusal Processed By Ib
Feb 28, 2024
Teas Response To Office Action Received
Feb 28, 2024
Correspondence Received In Law Office
Feb 28, 2024
Teas/Email Correspondence Entered
Feb 29, 2024
Examiners Amendment -Written
Feb 29, 2024
Examiners Amendment E-Mailed
Feb 29, 2024
Notification Of Examiners Amendment E-Mailed
Feb 29, 2024
Examiner's Amendment Entered
Feb 29, 2024
Approved For Pub - Principal Register
Mar 20, 2024
Notification Of Notice Of Publication E-Mailed
Mar 27, 2024
Notification Of Possible Opposition Sent To Ib
Mar 27, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 9, 2024
Published For Opposition
Apr 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 10, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 25, 2024
Registered-Principal Register
Apr 15, 2024
Notification Processed By Ib
Jun 25, 2024
Notice Of Registration Confirmation Emailed
Sep 25, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
